Highlights from this issue
Restriction of LABA use to combination ICS/LABA inhaler therapy in asthma
Weighing up risk factors for pneumonia
Co-trimoxazole for idiopathic pulmonary fibrosis
Airway inflammation in patients with chronic non-asthmatic cough
Aberrantly activated EGFR contributes to enhanced IL-8 expression in COPD airways epithelial cells via regulation of nuclear FoxO3A
TNFα antagonists for acute exacerbations of COPD
Longitudinal association between lung function and health-related quality of life in cystic fibrosis
Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole
The impact of benzodiazepines on occurrence of pneumonia and mortality from pneumonia
Lung-protective mechanical ventilation may be associated with a long-term survival benefit for patients with acute lung injury
Risk of pneumonia and pneumococcal disease in people with severe mental illness
Critical role of fractalkine (CX3CL1) in cigarette smoke-induced mononuclear cell adhesion to the arterial endothelium
Interstitial lung disease in patients with mixed connective tissue disease
Lung cancer resection rate is related to survival
Surgical resection of lung cancer in England
Eotaxins may contribute to both accumulation and elimination of eosinophils in asthma
Author's response to Persson letter
Electron tomography of respiratory cilia
Long-acting β-agonist prescribing in people with asthma in primary care
The FDA-mandated trial of safety of long-acting beta-agonists in asthma
Unexplained dyspnoea in a patient with idiopathic myelofibrosis